Evidence map›Paper›PMID 27388807›Full record

Trial reportBMC cancer2016

ColoNav: patient navigation for colorectal cancer screening in deprived areas - Study protocol.

C Allary, A Bourmaud, F Tinquaut, M Oriol, J Kalecinski, V Dutertre, N Lechopier, M Pommier, Y Benoist, S Rousseau and 3 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02369757 (Patients Navigator for Organized Colorectal Cancer Screening in Underserved Population), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02369757 nacompletednot on this map

Patients Navigator for Organized Colorectal Cancer Screening in Underserved Population

TypeinterventionalSponsorInstitut de Cancérologie de la LoireRan2012 to 2015Enrolled40,774ConditionsHealthyArmsNavigator intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

C AllaryHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.ORCID 0000-0001-9090-4158
A BourmaudHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France. aurelie.bourmaud@icloire.fr.
F TinquautHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
M OriolHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
J KalecinskiHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
V DutertreHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
N LechopierEA 4148 - S2HEP, University Lyon 1/Ecole Normale Supérieure de Lyon, 43, Boulevard du 11 novembre 1918, 69622, Villeurbanne cedex, France.
M PommierEA 4148 - S2HEP, University Lyon 1/Ecole Normale Supérieure de Lyon, 43, Boulevard du 11 novembre 1918, 69622, Villeurbanne cedex, France.
Y BenoistGustave Roussy Institut, 114 rue Edouard Vaillant, 94800, Villejuif, France.
S RousseauGustave Roussy Institut, 114 rue Edouard Vaillant, 94800, Villejuif, France.
V RegnierHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
V ButhionCOACTIS, Lumière University Lyon 2, 16 avenue Berthelot, 69007, Lyon, France.
F ChauvinHygée Centre, Lucien Neuwirth Cancer Institut- ICLN, CIC 1408 INSERM, 108bis avenue A. Raimond, 42270, Saint-Priest-en-Jarez, France.
Inserm · FRUniversité Claude Bernard Lyon 1 · FRInstitut Gustave Roussy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mass colorectal cancer screening program was implemented in 2008 in France, targeting 16 million French people aged between 50 and 74. The current adhesion is insufficient and the participation rate is even lower among the underserved population, increasing health inequalities within our health care system. Patient Navigation programs have proved their efficiency to promote the access to cancer screening and diagnosis. METHODS/

designThe purpose of the study is to assess the implementation of a patient navigation intervention that has been described in another cultural environment and another health care system. The main objective of the program is to increase the colorectal cancer screening participation rate among the deprived population through the intervention of a navigator to promote the Fecal Occult Blood Test (FOBT) and complementary exams. We performed a multisite cluster randomized controlled trial, with three groups (one experimental group and two control groups) for 18 months. DISCUSSION: The study attempts to give a better understanding of the adhesion barriers to colorectal cancer screening among underserved populations. If this project is cost-effective, it could create a dynamic based on peer approaches that could be developed for other cancer screening programs and other chronic diseases.

trial registrationNCT02369757.

Indexed as

AgedColorectal NeoplasmsCost-Benefit AnalysisEarly Detection of CancerFemaleFranceHealth Services AccessibilityHumansMaleMass ScreeningMiddle AgedPatient NavigationVulnerable PopulationsColorectal cancer screeningHealth inequalitiesImplementation researchPatient navigationRandomized control studyRealistic evaluation

Identifiers

PMID27388807
PMCPMC4936239
OpenAlexW3165945969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.